Pneumotox. vs ILD Helper
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
Pneumotox.
This app aids in diagnosing respiratory and cardiac diseases suspected of being drug-induced. It provides extensive information and bibliography from over 35,000 reviewed references, organized by causative drugs and respiratory patterns. It helps assess drug causality and offers diagnostic prompts.
- Diagnose drug-induced respiratory diseases
- Extensive bibliography from 35,000+ references
- Organized by causative drugs and respiratory patterns
- Drug causality assessment tool
- Diagnostic prompts and Naranjo scale integration
- Information on various drug administration routes
Read full descriptionHide full description
Pneumotox®: The drug-induced/iatrogenic respiratory disease website & App. The companion website and App Cardiotox® cover drug-induced cardiotoxicity. By Philippe Camus MD. Professor (emeritus) - Board-certified in pulmonary medicine and cardiology,- Université Bourgone-Europe, Dijon, France. Pneumotox is an aid to the diagnosis and management of respiratory diseases and reactions suspected of being induced by drugs, chemicals, and of iatrogenic origin. Causality assessment and exact diagnosis are the full responsibility of the user. Pneumotox is designed to provide regularly-updated information on drugs causing pulmonary toxicity (>1,700 agents), patterns of involvement (>820) and bibliography (>10,700 as of August 2026) within a few minutes. That may be the crux in emergency situations. Yet, double-checking in and from other sources is indicated. Pneumotox rests on a bibliographic repository built since 1978, which amounts to >50,000 references overall, the vast majority of which is indexed in PubMed. All references were and are carefully reviewed for reliability and causality by the founder, then indexed under the corresponding drug or agent in Pneumotox. Pneumotox can be assessed by causative drug(s), chemicals, herbals, substances of abuse, inhaled incl. e-cigarettes, vaping, inhalants, gases, ionizing radiations (providing the list of patterns), or by patterns of involvement (providing the list of causal drugs/agents). Drug names are generic (International Nonproprietary Names (INN), alphabetical), not brand ones. It may be appropriate to check the exact composition of any proprietary drug, as any other added substance or excipient can be pneumotoxic. Matching generic and brand names which differs with country is the responsibility of the user. Patterns are grouped by families according to the main anatomic site of involvement. If a drug or drug reaction is listed in Pneumotox, that does not equate the patient is demonstrating toxicity. A “Diagnosing DIRD” window in Pneumotox (top panel) may help secure the diagnosis. Lack of case or cases in the literature or in Pneumotox does not exclude a diagnosis of drug toxicity as there may be unpublished cases, you may be seeing the first case ever, or we may have overlooked some information. In such situations, please inform us; Pneumotox cannot be held responsible. Pneumotox can be contacted by mail 7/365 for complementary information, tailored literature, and/or data on rechallenge with the drug. In any patient, particularly the ones with acute respiratory failure, ARDS or acute bronchospasm, exposure to drugs, substances, and/or chemicals must be done exhaustively with the patient, and if needed with the family, health professionals, pharmacy and/or law enforcement personel. And prompt removal of the drug can be lifesaving. Caution: drug withdrawal can produce a flare of the underlying condition for which the drug was exactly given. Deliberate rechallenge can be hazardous as fatal relapse of the respiratiory reaction can supervene. Early sampling of body fluids for drug and/or metabolites is indicated as early as possible, particularly in the severely ill. Knowledge of toxidromes and antidotes capable of countering adverse effects of drugs or chemicals is essential (ex: PMID ). Where in doubt, consider double-checking PubMed, your affiliated Safety for Medicines Department/Agency and the Pharmacovigilance Department of drug companies. They may host more and/or undisclosed information. Patients should be reassured as such incidents are rare oveall. If needed, they are invited to consult with their treating physicians. Monitoring common causal agents (with red digits in stars) for impending toxicity is strongly advised. You may contact Pneumotox anytime through the contact window. ALL RIGHTS RESERVED The current version of Pneumotox website and App were developed by Akyos Communication Dijon France, under the guidance of Philippe Camus MD
ILD Helper
Read full descriptionHide full description
IMPORTANT: This app is offered and marketed as a general-purpose clinician documentation aid. It has NOT been reviewed, cleared, authorized, licensed, or approved by Health Canada, the FDA, or any regulatory authority for medical-device or clinical decision-support use. ILD Helper is a documentation utility for licensed healthcare professionals to organize clinical notes. It does NOT provide diagnosis, treatment recommendations, clinical decision support, or medical advice. Users are solely responsible for: • All clinical decisions • Compliance with privacy laws and institutional policies • Verifying all entered information • Professional judgment and patient care Not intended for use by patients or non-healthcare professionals. ### Features Section FEATURES: • Structured 22-step ILD consult workflow (history, exposures, investigations, case conference, clinician final notes) • Optional Premium subscription unlocks 10 additional workflow sections plus Review and export • Export draft clinical report as text, RTF, or PDF with medical-legal disclaimers (Premium) • Local-first storage - consult content stays on device unless the user exports or shares it • No analytics, tracking, or third-party services • Local audit logging for personal accountability • Configurable data retention policies • Privacy-focused design for de-identified use only DESIGNED FOR: • Pulmonologists • Respirologists • Internal Medicine specialists • Medical residents and fellows • Licensed healthcare professionals WHAT THIS APP IS NOT: Not offered or marketed as a medical device, diagnostic tool, or clinical decision support system Not a substitute for professional judgment Not validated for clinical use Not approved by any regulatory authority Not intended for patient self-assessment PRIVACY & DATA PRACTICES: Consult drafts stored locally in the app sandbox by default No developer-operated cloud synchronization for consult drafts No developer collection of consult narrative or analytics No analytics, usage tracking, or telemetry No advertising or third-party SDKs No developer-operated network service for consult content Apple StoreKit may be contacted for subscription verification Exports occur only through user-initiated copy, share, or export actions You are responsible for device security, institutional compliance, and handling of exported data. Copies may exist in backups, recipient systems, or downstream repositories outside the developer's control. MEDICAL-LEGAL DISCLAIMER: This software is provided "AS IS" without warranty. The developer is NOT liable for medical malpractice, data loss, privacy breaches, or any damages arising from use of this software. Users must: • Hold active professional licenses • Comply with HIPAA, PIPEDA, and applicable privacy laws • Follow institutional policies • Use only de-identified case labels (no patient names, DOB, MRN) Use of the app requires in-app acceptance of the End User License Agreement.
Screenshots
Verdict
The clearest difference is in-app purchases: Pneumotox. at none against ILD Helper's 2. Pneumotox. also leads on iOS requirement (16.4 vs 18). ILD Helper's advantage is update cadence (every 5 weeks vs every 42 months). On price, ads and device support there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. ILD Helper sells 2 in-app purchases, starting at $6.99 per month. Pneumotox. asks for nothing beyond the download.
Pneumotox. ships an update every 42 months, ILD Helper every 5 weeks. The most recent releases landed on October 10, 2026 and October 5, 2026 respectively.
| Parameter | Pneumotox. | ILD Helper |
|---|---|---|
| Price | Free | Free |
| Rating | 4.9 (7 ratings) — better | — |
| Positive reviews | 50.0% of reviews | — |
| Number of ratings | 7 — better | — |
| Update frequency | Every 42 months | Every 5 weeks — better |
| Ads | No | No |
| In-app purchases | No — better | Yes |
| Monetization | Free | — |
| Devices | iPhone, iPad | iPhone, iPad |
| Requires iOS | 16.4 — better | 18 |
| Further details — not scored | ||
| Size | 48 MB | 16 MB |
| Age rating | 17+ | 4+ |
| Developer | Philippe Camus | ABHISHEK KUMAR |
In-app purchases
Pneumotox.
No in-app purchases
ILD Helper
- ILD Helper Premium$6.991 Month
- ILD Helper Premium$69.991 Year
Questions
Is Pneumotox. free?
Is ILD Helper free?
Do Pneumotox. or ILD Helper have ads?
Which is updated more often, Pneumotox. or ILD Helper?
Other comparisons















